insights_auto
Why is ADPT down 9.85%?
Dive Deeperchevron_right
ADPT:NASDAQ
Adaptive Biotechnologies Corp
$26.90
arrow_downward
-9.85%(-2.94) 1D
$26.72
arrow_downward
-0.67% (-0.18)todayPre-market
Closed: Oct 6, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ADPT...
Open
$30.22
High
$30.74
Low
$26.85
Mkt. cap
4.08B
Avg. vol.
2.21M
Volume
4.63K
52-wk high
$30.74
52-wk low
$12.00
EPS
-$0.41
Beta
2.09
Shares outstanding
159.60M
No. of employees
624
Open
$30.22
High
$30.74
Low
$26.85
Mkt. cap
4.08B
Avg. vol.
2.21M
Volume
4.63K
52-wk high
$30.74
52-wk low
$12.00
EPS
-$0.41
Beta
2.09
Shares outstanding
159.60M
No. of employees
624
News stories
From web sources and news partners
Kalkine Media
·
14 hours ago
Adaptive Biotechnologies Officer Susan Bobulsky Files to Sell 6,444 Shares Under 10b5-1 Plan
Stock Titan
·
15 hours ago
Officer Susan Bobulsky proposes selling 6,444 Adaptive Biotechnologies (ADPT) shares.
MarketBeat
·
21 hours ago
Adaptive Biotechnologies (NASDAQ:ADPT) Hits New 52-Week High - Still a Buy?
Investing.com Nigeria
·
1 day ago
Form 4 Adaptive Biotechnologies Corp For: 5 October By Investing.com
About Adaptive Biotechnologies Corp
CEOChad Robins
Employees624
Founded2009
HeadquartersSeattle, Washington, United States
SectorHealth care
Websiteadaptivebiotech.com